Transaortic transcatheter aortic valve implantation: potential issues associated with the use of the ASCENDRA transapical delivery system

Luis Nombela-Franco; Josep Rodés-Cabau; Daniel Doyle; Robert Delarochellière; Marina Urena; Michael Mok; Eric Dumont

doi:10.1111/j.1540-8191.2012.01464.x

Transaortic transcatheter aortic valve implantation: potential issues associated with the use of the ASCENDRA transapical delivery system

J Card Surg. 2012 Jul;27(4):438-40. doi: 10.1111/j.1540-8191.2012.01464.x. Epub 2012 May 22.

Authors

Luis Nombela-Franco¹, Josep Rodés-Cabau, Daniel Doyle, Robert Delarochellière, Marina Urena, Michael Mok, Eric Dumont

Affiliation

¹ Department of Cardiology and Cardiac Surgery, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.

PMID: 22616946
DOI: 10.1111/j.1540-8191.2012.01464.x

Abstract

Transaortic transcatheter aortic valve implantation (TAo-TAVI) has been recently proposed as an alternative to transapical (TA) and transfemoral (TF) approach. We now discuss a technical issue associated with TAo-TAVI related to the use of a delivery system dedicated to the antegrade TA approach. The potential solutions to this issue as well as the potential advantages of the TAo approach are discussed.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged, 80 and over
Aortic Valve
Aortic Valve Stenosis / surgery*
Cardiac Catheterization / instrumentation
Cardiac Catheterization / methods*
Cardiac Catheters
Female
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation / instrumentation
Heart Valve Prosthesis Implantation / methods*
Humans